Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Shreya Chablaney"'
Publikováno v:
Clinical Endoscopy, Vol 50, Iss 6, Pp 530-536 (2017)
The incidence of rectal neuroendocrine tumors (NETs) has increased by almost ten-fold over the past 30 years. There has been a heightened awareness of the malignant potential of rectal NETs. Fortunately, many rectal NETs are discovered at earlier sta
Externí odkaz:
https://doaj.org/article/e85c2f46db2d44f69c9098b09fb77e38
Autor:
Shreya Chablaney, Rita M. Knotts
Publikováno v:
Foregut: The Journal of the American Foregut Society. 2:293-300
It is well established that there is an increased risk of esophageal malignancy associated with achalasia, with esophageal squamous cell carcinoma being the most common histologic subtype thought to be secondary to the detrimental effects of food and
Autor:
Christopher Vélez, Mary Paz, Casey Silvernale, Lawrence W. Stratton, Braden Kuo, Kyle Staller, Esteban Barreto, Josselyn Vergara Cobos, Kelly L. Buchanan, Taylor Boyd, Anshuman C. Desai, Shreya Chablaney, Ingrid Guerrero López, Joseph R. Betancourt
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:e1488-e1492
The first coronavirus disease 2019 (COVID-19) pandemic surge harshly impacted the medically underserved populations of the urbanized northeastern United States. Severe acute respiratory syndrome coronavirus 2 virions infect the gastrointestinal (GI)
Autor:
Yiran Zhang, Satimai Aniwan, A Weiss, Gursimran Kochhar, Sunanda V. Kane, Bo Shen, Matthew Bohm, Siddharth Singh, Eugenia Shmidt, Jean-Frederic Colombel, Corey A. Siegel, David Faleck, Edward V. Loftus, James P. Campbell, Mahmoud A. Rahal, Siri Kadire, Ronghui Xu, William J. Sandborn, David Hudesman, Arun Swaminath, Joseph Meserve, Robert Hirten, Vipul Jairath, Ryan C. Ungaro, Bruce E. Sands, Karen Lasch, Jenna L. Koliani-Pace, Brigid S. Boland, Parambir S. Dulai, Dana J. Lukin, Shreya Chablaney, Monika Fischer, Adam Winters, Gloria Tran, Shannon Chang, Sashidhar Varma
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Background & Aims We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice. Methods A multicenter, retrospective, observational cohort study (May 2014 to D
Autor:
Shreya Chablaney, Lawrence J. Brandt
Publikováno v:
Foregut: The Journal of the American Foregut Society. :263451612311702
The differential diagnosis of dysphagia is broad. A thorough history and physical examination are of paramount importance in determining the etiology of the patient’s dysphagia and guiding their subsequent management. This article discusses our app
Autor:
Bruce E. Sands, Robert Hirten, Keith Sultan, David Faleck, Jenna L. Koliani-Pace, Shannon Chang, Michelle Luo, Eugenia Shmidt, David Hudesman, William J. Sandborn, Youran Gao, Parambir S. Dulai, Bo Shen, Monika Fischer, Preeti Shashi, Dana J. Lukin, A Weiss, Sunanda V. Kane, Gursimran Kochhar, Jiao Yang, Arun Swaminath, Joseph Meserve, Satimai Aniwan, Edward V. Loftus, Siddharth Singh, Adam Winters, Matthew Bohm, Shreya Chablaney, Zhongwen Huang, Sashidhar Varma, Nitin Gupta, Brigid S. Boland, Karen Lasch, Jean-Frederic Colombel, Corey A. Siegel
Publikováno v:
Inflammatory Bowel Diseases
Background Vedolizumab effectiveness estimates immediately after Food and Drug Administration (FDA) approval for ulcerative colitis (UC) and Crohn’s disease (CD) are limited by use in refractory populations. We aimed to compare treatment patterns a
Autor:
Nikhil A. Kumta, Shreya Chablaney
Publikováno v:
Journal of Diabetes. 11:351-358
Endoscopic bariatric and metabolic therapies (EBMTs) have sparked significant interest as minimally invasive therapeutic options for weight loss. Although bariatric surgery remains an effective option for sustained weight loss and improvement in the
Autor:
Matthew, Bohm, Ronghui, Xu, Yiran, Zhang, Sashidhar, Varma, Monika, Fischer, Gursimran, Kochhar, Brigid, Boland, Siddharth, Singh, Robert, Hirten, Ryan, Ungaro, Eugenia, Shmidt, Karen, Lasch, Vipul, Jairaith, David, Hudesman, Shannon, Chang, Dana, Lukin, Arun, Swaminath, Bruce E, Sands, Jean-Frederic, Colombel, Sunanda, Kane, Edward V, Loftus, Bo, Shen, Corey A, Siegel, William J, Sandborn, Parambir S, Dulai, Shreya, Chablaney
Publikováno v:
Alimentary Pharmacology & Therapeutics
Background Direct comparisons are lacking between vedolizumab and tumour necrosis factor (TNF)-antagonist therapy in Crohn's disease (CD). Aim To compare safety and effectiveness of vedolizumab and TNF-antagonist therapy in adult CD patients. Methods
Publikováno v:
Clinical Endoscopy
Clinical Endoscopy, Vol 50, Iss 6, Pp 530-536 (2017)
Clinical Endoscopy, Vol 50, Iss 6, Pp 530-536 (2017)
The incidence of rectal neuroendocrine tumors (NETs) has increased by almost ten-fold over the past 30 years. There has been a heightened awareness of the malignant potential of rectal NETs. Fortunately, many rectal NETs are discovered at earlier sta
Autor:
Shannon Chang, Dana J. Lukin, Maria Rosario, Bo Shen, David Faleck, Arun Swaminath, Joseph Meserve, Satimai Aniwan, Ryan C. Ungaro, David Hudesman, A Weiss, Brigid S. Boland, Gursimran Kochhar, Robert Hirten, Nitin Gupta, Vipul Jairath, Sashidhar Varma, Karen Lasch, Eugenia Shmidt, Preeti Shashi, Siddharth Singh, Matthew Bohm, Brian G. Feagan, Sunanda V. Kane, Bruce E. Sands, Shreya Chablaney, Jean-Frederic Colombel, Jenna L. Koliani-Pace, Edward V. Loftus, Corey A. Siegel, Adam Winters, John T. Chang, Charlie Cao, Keith Sultan, Leonardo Guizzetti, Parambir S. Dulai, William J. Sandborn, Youran Gao, Monika Fischer, Niels Vande Casteele
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 18, iss 13
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 18, iss 13
Background & aimsWe created and validated a clinical decision support tool (CDST) to predict outcomes of vedolizumab therapy for ulcerative colitis (UC).MethodsWe performed logistic regression analyses of data from the GEMINI 1 trial, from 620 patien